Fulminant myocarditis (Q37271422)

19 August 2017

1 reference

title

Fulminant myocarditis. (English)

1 reference

19 August 2017

Sachin Gupta

1 reference

19 August 2017

David W Markham

series ordinal

1 reference

19 August 2017

Mark H Drazner

series ordinal

1 reference

19 August 2017

Pradeep Pa Mammen

series ordinal

1 reference

19 August 2017

publication date

16 September 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

19 August 2017

published in

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

693-706

1 reference

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

The role of transgenic knockout models in defining the pathogenesis of viral heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

Expression of major histocompatibility complex class I antigen in murine ventricular myocytes infected with Coxsackievirus B3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

Prognostic value of posterior wall thickness in childhood dilated cardiomyopathy and myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Myocarditis: current trends in diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Sudden unexpected death in persons less than 40 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Sudden cardiac death in Air Force recruits. A 20-year review

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

The Genetics of Dilated Cardiomyopathy — Emerging Clues to the Puzzle

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

The role of cytoskeletal proteins in cardiomyopathies

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Coronary microvascular narrowing in acute murine coxsackie B3 myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Contribution of the innate immune system to autoimmune myocarditis: a role for complement

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Echocardiographic findings in fulminant and acute myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Risk factors for patients developing a fulminant course with acute myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Predictive factors of a fulminant course in acute myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Acute necrotising eosinophilic myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Peripartum myocarditis and cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Outcome of heart transplantation in patients with sarcoid cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Giant cell myocarditis: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

A case of giant cell myocarditis and malignant thymoma: a postmortem diagnosis by needle biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Giant cell myocarditis as a manifestation of drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Giant cell and granulomatous myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

1 reference

7 January 2021

A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

One-Year Survival Following Early Revascularization for Cardiogenic Shock

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Echocardiographic findings in myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Interobserver variability in the pathologic interpretation of endomyocardial biopsy results

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Clinicopathologic description of myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Mechanical circulatory support for patients with acute-fulminant myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Regression of cellular hypertrophy after left ventricular assist device support

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Management of acute fulminant myocarditis using circulatory support systems

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Effect of circulatory assist devices on stunned myocardium

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Myocardial recovery after mechanical support for acute myocarditis: is sustained recovery predictable?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Advances in the understanding of myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1331

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1331

1 reference

Dimensions Publication ID

19 August 2017

1021149315

0 references

Fatcat ID

release_gswbryfbgjgflkxeuhrt65zazy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gswbryfbgjgflkxeuhrt65zazy

24 November 2022

mapped directly with Wikidata item

1 reference